Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 5, Issue 4, Pages 416-423Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1367-5931(00)00223-4
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI48506] Funding Source: Medline
- NIGMS NIH HHS [GM 55242] Funding Source: Medline
Ask authors/readers for more resources
Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways. Recent gene knockout studies in mice identify PTP1B as a promising target for anti-diabetes/obesity drug discovery. PTPs are also implicated in a wide variety of other disorders, including cancer. Significant progress has been made in identifying small molecules that simultaneously bind both the active site and a unique adjacent site that enables specific inhibition of individual PTP isoenzymes. As a consequence, there are compelling reasons to believe that PTP inhibitors may ultimately serve as powerful therapeutic weapons in our arsenal for battling human diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available